| scholarly article | Q13442814 |
| P50 | author | Yoshihiro Kawaoka | Q2600945 |
| P2093 | author name string | Mutsumi Ito | |
| Taisuke Horimoto | |||
| Shin Murakami | |||
| Hiroaki Katsura | |||
| Masayuki Shimojima | |||
| Ryo Takano | |||
| P2860 | cites work | Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes | Q24614628 |
| Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses | Q24649949 | ||
| Antibody recognition of a highly conserved influenza virus epitope | Q24655932 | ||
| Visualizing infection of individual influenza viruses | Q24681388 | ||
| Viral membrane fusion | Q27486639 | ||
| Structural Characterization of an Early Fusion Intermediate of Influenza Virus Hemagglutinin | Q27667137 | ||
| Generation of influenza A viruses entirely from cloned cDNAs | Q29616768 | ||
| Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial | Q30226730 | ||
| The predicted antigenicity of the haemagglutinin of the 1918 Spanish influenza pandemic suggests an avian origin. | Q30329363 | ||
| From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza. | Q30342973 | ||
| Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. | Q30343761 | ||
| Avian flu: isolation of drug-resistant H5N1 virus. | Q30351638 | ||
| Enhanced growth of seed viruses for H5N1 influenza vaccines | Q30363037 | ||
| Establishment of canine RNA polymerase I-driven reverse genetics for influenza A virus: its application for H5N1 vaccine production | Q30366174 | ||
| A clinical trial of a whole-virus H5N1 vaccine derived from cell culture. | Q30369945 | ||
| Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines. | Q30376550 | ||
| A cell culture (Vero)-derived H5N1 whole-virus vaccine induces cross-reactive memory responses. | Q30380169 | ||
| Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. | Q30380578 | ||
| Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine | Q30388038 | ||
| High Level of Genetic Compatibility between Swine-Origin H1N1 and Highly Pathogenic Avian H5N1 Influenza Viruses | Q30392309 | ||
| Primary cell cultures from murine kidney and heart differ in endosomal pH. | Q32061701 | ||
| Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies | Q33328393 | ||
| A measure of endosomal pH by flow cytometry in Dictyostelium | Q33399286 | ||
| The pH of activation of the hemagglutinin protein regulates H5N1 influenza virus pathogenicity and transmissibility in ducks. | Q33614501 | ||
| Safe administration of influenza vaccine to patients with egg allergy. | Q34480535 | ||
| Safety and immunogenicity of inactivated, Vero cell culture-derived whole virus influenza A/H5N1 vaccine given alone or with aluminum hydroxide adjuvant in healthy adults | Q34498228 | ||
| Endocytosis of influenza viruses | Q35862726 | ||
| An adenovirus vector-mediated reverse genetics system for influenza A virus generation | Q35947953 | ||
| Glycosylation does not determine segregation of viral envelope proteins in the plasma membrane of epithelial cells | Q36204345 | ||
| Defective interfering influenza viruses and host cells: establishment and maintenance of persistent influenza virus infection in MDBK and HeLa cells | Q36508992 | ||
| Amino acid residues in the fusion peptide pocket regulate the pH of activation of the H5N1 influenza virus hemagglutinin protein. | Q37145184 | ||
| High titer growth of human and avian influenza viruses in an immortalized chick embryo cell line without the need for exogenous proteases | Q39975393 | ||
| Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture. | Q40317988 | ||
| Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children | Q40755954 | ||
| Adaptation of Egg-Grown and Transfectant Influenza Viruses for Growth in Mammalian Cells: Selection of Hemagglutinin Mutants with Elevated pH of Membrane Fusion | Q41100031 | ||
| Amino acid sequence identity between the HA1 of influenza A (H3N2) viruses grown in mammalian and primary chick kidney cells | Q41625463 | ||
| Development of Vero cell-derived inactivated Japanese encephalitis vaccine | Q43040869 | ||
| Avian influenza virus A/chicken/Hubei/489/2004 (H5N1) induces caspase-dependent apoptosis in a cell-specific manner | Q44117766 | ||
| Crystal structure of the low-pH form of the vesicular stomatitis virus glycoprotein G. | Q45414549 | ||
| Differential Requirements of Rab5 and Rab7 for Endocytosis of Influenza and Other Enveloped Viruses | Q47953724 | ||
| Cell culture as a substrate for the production of influenza vaccines: memorandum from a WHO meeting | Q57118995 | ||
| Polio and rabies vaccines produced in continuous cell lines: a reality for Vero cell line | Q69678218 | ||
| Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine | Q82769653 | ||
| Oseltamivir resistance in influenza A (H5N1) infection | Q95797642 | ||
| P433 | issue | 3 | |
| P921 | main subject | influenza vaccine | Q383260 |
| P304 | page(s) | 1405-1410 | |
| P577 | publication date | 2011-11-16 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Enhanced growth of influenza vaccine seed viruses in vero cells mediated by broadening the optimal pH range for virus membrane fusion | |
| P478 | volume | 86 |
| Q41635128 | A Vero-cell-adapted vaccine donor strain of influenza A virus generated by serial passages |
| Q41754686 | A histidine residue of the influenza virus hemagglutinin controls the pH dependence of the conformational change mediating membrane fusion. |
| Q35415045 | A recommended numbering scheme for influenza A HA subtypes |
| Q30357539 | A single amino acid in the stalk region of the H1N1pdm influenza virus HA protein affects viral fusion, stability and infectivity. |
| Q30364511 | Acid-induced membrane fusion by the hemagglutinin protein and its role in influenza virus biology. |
| Q90629411 | Adaptation of H3N2 canine influenza virus to feline cell culture |
| Q30430005 | An MDCK cell culture-derived formalin-inactivated influenza virus whole-virion vaccine from an influenza virus library confers cross-protective immunity by intranasal administration in mice |
| Q47406183 | Animal Cell Expression Systems |
| Q52644045 | Characterization of H5N1 influenza virus quasispecies with adaptive hemagglutinin mutations from single-virus infections of human airway cells. |
| Q30373481 | Characterization of H5N1 influenza virus variants with hemagglutinin mutations isolated from patients |
| Q42147064 | Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines |
| Q30387186 | Construction high-yield candidate influenza vaccine viruses in Vero cells by reassortment |
| Q35126733 | Development of a novel, single-cycle replicable rift valley Fever vaccine |
| Q36084675 | Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells |
| Q35869278 | Downregulating viral gene expression: codon usage bias manipulation for the generation of novel influenza A virus vaccines. |
| Q42250053 | Egg- or cell culture-derived hemagglutinin mutations impair virus stability and antigen content of inactivated influenza vaccines. |
| Q30384897 | Genetic characterization of an adapted pandemic 2009 H1N1 influenza virus that reveals improved replication rates in human lung epithelial cells. |
| Q30381890 | H1N1 Swine Influenza Viruses Differ from Avian Precursors by a Higher pH Optimum of Membrane Fusion. |
| Q90616762 | HA-Dependent Tropism of H5N1 and H7N9 Influenza Viruses to Human Endothelial Cells Is Determined by Reduced Stability of the HA, Which Allows the Virus To Cope with Inefficient Endosomal Acidification and Constitutively Expressed IFITM3 |
| Q92042877 | Identification of key hemagglutinin residues responsible for cleavage, acid stability, and virulence of fifth-wave highly pathogenic avian influenza A(H7N9) viruses |
| Q30432710 | Increased acid stability of the hemagglutinin protein enhances H5N1 influenza virus growth in the upper respiratory tract but is insufficient for transmission in ferrets |
| Q37070609 | Influenza A/Hong Kong/156/1997(H5N1) virus NS1 gene mutations F103L and M106I both increase IFN antagonism, virulence and cytoplasmic localization but differ in binding to RIG-I and CPSF30 |
| Q54230830 | Influenza Hemagglutinin Protein Stability, Activation, and Pandemic Risk. |
| Q92689668 | Influenza Virus with Increased pH of Hemagglutinin Activation Has Improved Replication in Cell Culture but at the Cost of Infectivity in Human Airway Epithelium |
| Q30369380 | Influenza virus M2 protein ion channel activity helps to maintain pandemic 2009 H1N1 virus hemagglutinin fusion competence during transport to the cell surface. |
| Q38768213 | Is the optimal pH for membrane fusion in host cells by avian influenza viruses related to host range and pathogenicity? |
| Q38858977 | Modulation of the pH Stability of Influenza Virus Hemagglutinin: A Host Cell Adaptation Strategy |
| Q30355996 | Recombinant influenza A H3N2 viruses with mutations of HA transmembrane cysteines exhibited altered virological characteristics. |
| Q39309001 | Reverse Genetics of Influenza B Viruses |
| Q37584477 | Single PA mutation as a high yield determinant of avian influenza vaccines |
| Q36433824 | The C-type Lectin Langerin Functions as a Receptor for Attachment and Infectious Entry of Influenza A Virus |
| Q30365696 | The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccines |
| Q36759926 | The pH of activation of the hemagglutinin protein regulates H5N1 influenza virus replication and pathogenesis in mice |
| Q36174023 | Viral RNA Degradation and Diffusion Act as a Bottleneck for the Influenza A Virus Infection Efficiency |
| Q30400470 | pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs |
Search more.